Full Archive

The downside of upside

There is no question even with Covid the markets have been on a roll. After taking an initial hit the markets have come roaring back hitting new highs. This is great news for investors of course but there is a downside to all this goodness. It provides the fuel companies need to stay alive even when their product and/or service doesn’t stand an ice cubes chance in hell of being...

Every day is Labor Day

Before we get into the gist of today’s post, we’d like to wish everyone a great Labor Day weekend and to our fellow tribe members a happy, healthy and prosperous New Year. We’d also like to thank the many who have already donated for my upcoming triathlon which goes off next Sunday September 12 here in beautiful San Diego. Please check out doingitthreeways.com and please donate if you can as...

It’s Podcast Day

Yes, if it’s Wednesday it must be time for another addition of the Wacky World of Diabetes podcast. Today is another in a series of patients with diabetes who’ve taken the next step and are trying to make our wacky world a better place. Today meet Scott Strumello who describes himself on LinkedIn as a Badass Retail Bank/Credit Card Product Management, Content Management, and Digital Marketing Exec who solves problems...

Value destruction

Looking at the results released by Medtronic this morning it’s difficult to find a silver lining among the very dark clouds. You know the diabetes unit has major issues when the company highlights growth in emerging markets which is nice until you consider the size of these markets. Domestically sales fell 15% while in developed markets outside the US sales grew an anemic 6.2%. The company seems to believe that their...

New failure same problem

There’s a sign in the office here that says, “If it was easy everyone would do it”. While it wasn’t directed at our wacky world it sure as hell could have been. News is circulating that Google, yes Google, while still in healthcare is restructuring their initiatives. So far, we have not heard if this latest restructuring impacts Verily, the company’s life sciences unit which was supposed to go public...

Data or Dollars

In our continuing quest to educate we thought it best to provide some perspective on the difference between drugs and devices when it comes to investing. We felt this was timely as recently we have seen more money flow into the CGM wannabe arena. Now in the interest of fairness we shall not provide the names of the companies which received money, nor will we embarrass the fools who invested...

A new twist on the Podcast

In our never-ending attempt to educate everyone on this wacky world of ours we’re taking a slightly different track with our next few podcasts. Yes, we know it’s great to hear from respected researchers who have dedicated their lives to diabetes – and just a quick shout out to a former podcast guest Dr. Steven Edelman who will be receiving the ADCES Lifetime Achievement Award a well-deserved honor to this...